Physical and structural basis for polymorphism in amyloid fibrils

Protein Science

Volumn 23, Issue 11, 2014, Pages 1528-1539

  Tycko, Robert ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Alzheimer's disease; amyloid structure; fibril structure; prion; solid state NMR

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CHEMICAL STRUCTURE; ELECTRON MICROSCOPY; HYDROGEN BOND; MOLECULAR DYNAMICS; NITROGEN NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN STRUCTURE; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION; CHEMISTRY; METABOLISM; PROTEIN CONFORMATION; ULTRASTRUCTURE;

AMYLOID; AMYLOID BETA-PEPTIDES; MODELS, MOLECULAR; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PROTEIN CONFORMATION;

EID: 84908675131     PISSN: 09618368     EISSN: 1469896X     Source Type: Journal    
DOI: 10.1002/pro.2544     Document Type: Article

References (112)

1. Astbury WT, Beighton E, Parker KD, (1959) The cross-b configuration in supercontracted proteins. Biochim Biophys Acta 35: 17-25.
2. Nelson R, Sawaya MR, Balbirnie M, Madsen AO, Riekel C, Grothe R, Eisenberg D, (2005) Structure of the cross-b spine of amyloid-like fibrils. Nature 435: 773-778.
3. Sawaya MR, Sambashivan S, Nelson R, Ivanova MI, Sievers SA, Apostol MI, Thompson MJ, Balbirnie M, Wiltzius JJW, McFarlane HT, Madsen AO, Riekel C, Eisenberg D, (2007) Atomic structures of amyloid cross-b spines reveal varied steric zippers. Nature 447: 453-457.
4. Eanes ED, Glenner GG, (1968) X-ray diffraction studies on amyloid filaments. J Histochem Cytochem 16: 673-677.
5. Baxa U, Cheng NQ, Winkler DC, Chiu TK, Davies DR, Sharma D, Inouye H, Kirschner DA, Wickner RB, Steven AC, (2005) Filaments of the Ure2p prion protein have a cross-b core structure. J Struct Biol 150: 170-179.
6. Serpell LC, Smith JM, (2000) Direct visualisation of the b-sheet structure of synthetic Alzheimer's amyloid. J Mol Biol 299: 225-231.
7. Oyler NA, Tycko R, (2004) Absolute structural constraints on amyloid fibrils from solid state NMR spectroscopy of partially oriented samples. J Am Chem Soc 126: 4478-4479.
8. Chiti F, Webster P, Taddei N, Clark A, Stefani M, Ramponi G, Dobson CM, (1999) Designing conditions for in vitro formation of amyloid protofilaments and fibrils. Proc Natl Acad Sci USA 96: 3590-3594.
9. Jimenez JL, Guijarro JL, Orlova E, Zurdo J, Dobson CM, Sunde M, Saibil HR, (1999) Cryo-electron microscopy structure of an SH3 amyloid fibril and model of the molecular packing. Embo J 18: 815-821.
10. MacPhee CE, Dobson CM, (2000) Formation of mixed fibrils demonstrates the generic nature and potential utility of amyloid nanostructures. J Am Chem Soc 122: 12707-12713.
11. Ritter C, Maddelein ML, Siemer AB, Luhrs T, Ernst M, Meier BH, Saupe SJ, Riek R, (2005) Correlation of structural elements and infectivity of the HET-s prion. Nature 435: 844-848.
12. Fowler DM, Koulov AV, Alory-Jost C, Marks MS, Balch WE, Kelly JW, (2006) Functional amyloid formation within mammalian tissue. PLoS Biol 4: 100-107.
13. Hammer ND, Schmidt JC, Chapman MR, (2007) The curli nucleator protein, CsgB, contains an amyloidogenic domain that directs CsgA polymerization. Proc Natl Acad Sci USA 104: 12494-12499.
14. Shewmaker F, McGlinchey RP, Thurber KR, McPhie P, Dyda F, Tycko R, Wickner RB, (2009) The functional curli amyloid is not based on in-register parallel b-sheet structure. J Biol Chem 284: 25065-25076.
15. Hu KN, McGlinchey RP, Wickner RB, Tycko R, (2011) Segmental polymorphism in a functional amyloid. Biophys J 101: 2242-2250.
16. Shewmaker F, McGlinchey RP, Wickner RB, (2011) Structural insights into functional and pathological amyloid. J Biol Chem 286: 16533-16540.
17. Li JX, McQuade T, Siemer AB, Napetschnig J, Moriwaki K, Hsiao YS, Damko E, Moquin D, Walz T, McDermott A, Chan FKM, Wu H, (2012) The Rip1/Rip3 necrosome forms a functional amyloid signaling complex required for programmed necrosis. Cell 150: 339-350.
18. Macindoe I, Kwan AH, Ren Q, Morris VK, Yang WR, Mackay JP, Sunde M, (2012) Self-assembly of functional, amphipathic amyloid monolayers by the fungal hydrophobin EAS. Proc Natl Acad Sci USA 109: E804-E811.
19. Kato M, Han TNW, Xie SH, Shi K, Du XL, Wu LC, Mirzaei H, Goldsmith EJ, Longgood J, Pei JM, Grishin NV, Frantz DE, Schneider JW, Chen S, Li L, Sawaya MR, Eisenberg D, Tycko R, McKnight SL, (2012) Cell-free formation of RNA granules: low complexity sequence domains form dynamic fibers within hydrogels. Cell 149: 753-767.
20. Ader C, Frey S, Maas W, Schmidt HB, Gorlich D, Baldus M, (2010) Amyloid-like interactions within nucleoporin FG hydrogels. Proc Natl Acad Sci USA 107: 6281-6285.
21. Sacchettini JC, Kelly JW, (2002) Therapeutic strategies for human amyloid diseases. Nat Rev Drug Discov 1: 267-275.
22. Kung HF, Choi SR, Qu WC, Zhang W, Skovronsky D, (2010) 18F stilbenes and styrylpyridines for PET imaging of Ab plaques in Alzheimer's disease: A miniperspective. J Med Chem 53: 933-941.
23. Fleisher AS, Chen KW, Liu XF, Roontiva A, Thiyyagura P, Ayutyanont N, Joshi AD, Clark CM, Mintun MA, Pontecorvo MJ, Doraiswamy PM, Johnson KA, Skovronsky DM, Reiman EM, (2011) Using positron emission tomography and florbetapir 18F to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease. Arch Neurol 68: 1404-1411.
24. Mathis CA, Wang YM, Holt DP, Huang GF, Debnath ML, Klunk WE, (2003) Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents. J Med Chem 46: 2740-2754.
25. Klunk WE, Engler H, Nordberg A, Wang YM, Blomqvist G, Holt DP, Bergstrom M, Savitcheva I, Huang GF, Estrada S, Ausen B, Debnath ML, Barletta J, Price JC, Sandell J, Lopresti BJ, Wall A, Koivisto P, Antoni G, Mathis CA, Langstrom B, (2004) Imaging brain amyloid in Alzheimer's disease with Pittsburgh compound B. Ann Neurol 55: 306-319.
26. Antzutkin ON, Balbach JJ, Leapman RD, Rizzo NW, Reed J, Tycko R, (2000) Multiple quantum solid state NMR indicates a parallel, not antiparallel, organization of b-sheets in Alzheimer's b-amyloid fibrils. Proc Natl Acad Sci USA 97: 13045-13050.
27. Balbach JJ, Ishii Y, Antzutkin ON, Leapman RD, Rizzo NW, Dyda F, Reed J, Tycko R, (2000) Amyloid fibril formation by a b(16-22), a seven-residue fragment of the Alzheimer's b-amyloid peptide, and structural characterization by solid state NMR. Biochemistry 39: 13748-13759.
28. Antzutkin ON, Leapman RD, Balbach JJ, Tycko R, (2002) Supramolecular structural constraints on Alzheimer's b-amyloid fibrils from electron microscopy and solid state nuclear magnetic resonance. Biochemistry 41: 15436-15450.
29. Balbach JJ, Petkova AT, Oyler NA, Antzutkin ON, Gordon DJ, Meredith SC, Tycko R, (2002) Supramolecular structure in full-length Alzheimer's b-amyloid fibrils: evidence for a parallel b-sheet organization from solid state nuclear magnetic resonance. Biophys J 83: 1205-1216.
30. Antzutkin ON, Balbach JJ, Tycko R, (2003) Site-specific identification of non-b-strand conformations in Alzheimer's b-amyloid fibrils by solid state NMR. Biophys J 84: 3326-3335.
31. Petkova AT, Buntkowsky G, Dyda F, Leapman RD, Yau WM, Tycko R, (2004) Solid state NMR reveals a ph-dependent antiparallel b-sheet registry in fibrils formed by a b-amyloid peptide. J Mol Biol 335: 247-260.
32. Petkova AT, Leapman RD, Guo ZH, Yau WM, Mattson MP, Tycko R, (2005) Self-propagating, molecular-level polymorphism in Alzheimer's b-amyloid fibrils. Science 307: 262-265.
33. Sciarretta KL, Gordon DJ, Petkova AT, Tycko R, Meredith SC, (2005) Ab40-lactam(D23/K28) models a conformation highly favorable for nucleation of amyloid. Biochemistry 44: 6003-6014.
34. Paravastu AK, Petkova AT, Tycko R, (2006) Polymorphic fibril formation by residues 10-40 of the Alzheimer's b-amyloid peptide. Biophys J 90: 4618-4629.
35. Petkova AT, Yau WM, Tycko R, (2006) Experimental constraints on quaternary structure in Alzheimer's b-amyloid fibrils. Biochemistry 45: 498-512.
36. Bu ZM, Shi Y, Callaway DJE, Tycko R, (2007) Molecular alignment within b-sheets in Ab14-23 fibrils: solid state NMR experiments and theoretical predictions. Biophys J 92: 594-602.
37. Paravastu AK, Leapman RD, Yau WM, Tycko R, (2008) Molecular structural basis for polymorphism in Alzheimer's b-amyloid fibrils. Proc Natl Acad Sci USA 105: 18349-18354.
38. Paravastu AK, Qahwash I, Leapman RD, Meredith SC, Tycko R, (2009) Seeded growth of b-amyloid fibrils from Alzheimer's brain-derived fibrils produces a distinct fibril structure. Proc Natl Acad Sci USA 106: 7443-7448.
39. Tycko R, Sciarretta KL, Orgel J, Meredith SC, (2009) Evidence for novel b-sheet structures in Iowa mutant b-amyloid fibrils. Biochemistry 48: 6072-6084.
40. Qiang W, Yau WM, Tycko R, (2011) Structural evolution of Iowa mutant b-amyloid fibrils from polymorphic to homogeneous states under repeated seeded growth. J Am Chem Soc 133: 4018-4029.
41. Qiang W, Yau WM, Luo YQ, Mattson MP, Tycko R, (2012) Antiparallel b-sheet architecture in Iowa mutant b-amyloid fibrils. Proc Natl Acad Sci USA 109: 4443-4448.
42. Lu JX, Qiang W, Yau WM, Schwieters CD, Meredith SC, Tycko R, (2013) Molecular structure of b-amyloid fibrils in Alzheimer's disease brain tissue. Cell 154: 1257-1268.
43. Qiang W, Kelley K, Tycko R, (2013) Polymorph-specific kinetics and thermodynamics of b-amyloid fibril growth. J Am Chem Soc 135: 6860-6871.
44. Shewmaker F, Wickner RB, Tycko R, (2006) Amyloid of the prion domain of Sup35p has an in-register parallel b-sheet structure. Proc Natl Acad Sci USA 103: 19754-19759.
45. Baxa U, Wickner RB, Steven AC, Anderson DE, Marekov LN, Yau WM, Tycko R, (2007) Characterization of b-sheet structure in Ure2p1-89 yeast prion fibrils by solid state nuclear magnetic resonance. Biochemistry 46: 13149-13162.
46. Shewmaker F, Ross ED, Tycko R, Wickner RB, (2008) Amyloids of shuffled prion domains that form prions have a parallel in-register b-sheet structure. Biochemistry 47: 4000-4007.
47. Wickner RB, Dyda F, Tycko R, (2008) Amyloid of Rnq1p, the basis of the [PIN+] prion, has a parallel in-register b-sheet structure. Proc Natl Acad Sci USA 105: 2403-2408.
48. Shewmaker F, Kryndushkin D, Chen B, Tycko R, Wickner RB, (2009) Two prion variants of Sup35p have in-register parallel b-sheet structures, independent of hydration. Biochemistry 48: 5074-5082.
49. Kryndushkin DS, Wickner RB, Tycko R, (2011) The core of Ure2p prion fibrils is formed by the N-terminal segment in a parallel cross-b structure: Evidence from solid state NMR. J Mol Biol 409: 263-277.
50. Tycko R, Savtchenko R, Ostapchenko VG, Makarava N, Baskakov IV, (2010) The α-helical C-terminal domain of full-length recombinant PrP converts to an in-register parallel b-sheet structure in PrP fibrils: Evidence from solid state nuclear magnetic resonance. Biochemistry 49: 9488-9497.
51. Luca S, Yau WM, Leapman R, Tycko R, (2007) Peptide conformation and supramolecular organization in amylin fibrils: Constraints from solid state NMR. Biochemistry 46: 13505-13522.
52. Torok M, Milton S, Kayed R, Wu P, McIntire T, Glabe CG, Langen R, (2002) Structural and dynamic features of Alzheimer's Ab peptide in amyloid fibrils studied by site-directed spin labeling. J Biol Chem 277: 40810-40815.
53. Der-Sarkissian A, Jao CC, Chen J, Langen R, (2003) Structural organization of a-synuclein fibrils studied by site-directed spin labeling. J Biol Chem 278: 37530-37535.
54. Margittai M, Langen R, (2004) Template-assisted filament growth by parallel stacking of tau. Proc Natl Acad Sci USA 101: 10278-10283.
55. Chen M, Margittai M, Chen J, Langen R, (2007) Investigation of a-synuclein fibril structure by site-directed spin labeling. J Biol Chem 282: 24970-24979.
56. Benzinger TLS, Gregory DM, Burkoth TS, Miller-Auer H, Lynn DG, Botto RE, Meredith SC, (1998) Propagating structure of Alzheimer's b-amyloid(10-35) is parallel b-sheet with residues in exact register. Proc Natl Acad Sci USA 95: 13407-13412.
57. Jaroniec CP, MacPhee CE, Bajaj VS, McMahon MT, Dobson CM, Griffin RG, (2004) High-resolution molecular structure of a peptide in an amyloid fibril determined by magic angle spinning NMR spectroscopy. Proc Natl Acad Sci USA 101: 711-716.
58. Heise H, Hoyer W, Becker S, Andronesi OC, Riedel D, Baldus M, (2005) Molecular-level secondary structure, polymorphism, and dynamics of full-length a-synuclein fibrils studied by solid state NMR. Proc Natl Acad Sci USA 102: 15871-15876.
59. van der Wel PCA, Lewandowski JR, Griffin RG, (2007) Solid state NMR study of amyloid nanocrystals and fibrils formed by the peptide GNNQQNY from yeast prion protein Sup35p. J Am Chem Soc 129: 5117-5130.
60. Andronesi OC, von Bergen M, Biernat J, Seidel K, Griesinger C, Mandelkow E, Baldus M, (2008) Characterization of Alzheimer's-like paired helical filaments from the core domain of tau protein using solid state NMR spectroscopy. J Am Chem Soc 130: 5922-5928.
61. Heise H, Celej MS, Becker S, Riede D, Pelah A, Kumar A, Jovin TM, Baldus M, (2008) Solid state NMR reveals structural differences between fibrils of wild-type and disease-related A53T mutant a-synuclein. J Mol Biol 380: 444-450.
62. Helmus JJ, Surewicz K, Nadaud PS, Surewicz WK, Jaroniec CP, (2008) Molecular conformation and dynamics of the Y145Stop variant of human prion protein. Proc Natl Acad Sci U S A 105: 6284-6289.
63. Verel R, Tomka IT, Bertozzi C, Cadalbert R, Kammerer RA, Steinmetz MO, Meier BH, (2008) Polymorphism in an amyloid-like fibril-forming model peptide. Angew Chem-Int Edit 47: 5842-5845.
64. Walsh P, Simonetti K, Sharpe S, (2009) Core structure of amyloid fibrils formed by residues 106-126 of the human prion protein. Structure 17: 417-426.
65. Ahmed M, Davis J, Aucoin D, Sato T, Ahuja S, Aimoto S, Elliott JI, Van Nostrand WE, Smith SO, (2010) Structural conversion of neurotoxic amyloid-b(1-42) oligomers to fibrils. Nat Struct Mol Biol 17: 561-U556.
66. Bayro MJ, Maly T, Birkett NR, MacPhee CE, Dobson CM, Griffin RG, (2010) High-resolution MAS NMR analysis of PI3-SH3 amyloid fibrils: Backbone conformation and implications for protofilament assembly and structure. Biochemistry 49: 7474-7484.
67. Debelouchina GT, Platt GW, Bayro MJ, Radford SE, Griffin RG, (2010) Magic angle spinning NMR analysis of b2-microglobulin amyloid fibrils in two distinct morphologies. J Am Chem Soc 132: 10414-10423.
68. Debelouchina GT, Platt GW, Bayro MJ, Radford SE, Griffin RG, (2010) Intermolecular alignment in b2-microglobulin amyloid fibrils. J Am Chem Soc 132: 17077-17079.
69. Helmus JJ, Surewicz K, Surewicz WK, Jaroniec CP, (2010) Conformational flexibility of Y145Stop human prion protein amyloid fibrils probed by solid state nuclear magnetic resonance spectroscopy. J Am Chem Soc 132: 2393-2403.
70. Bertini I, Gonnelli L, Luchinat C, Mao JF, Nesi A, (2011) A new structural model of Ab(40) fibrils. J Am Chem Soc 133: 16013-16022.
71. Comellas G, Lemkau LR, Nieuwkoop AJ, Kloepper KD, Ladror DT, Ebisu R, Woods WS, Lipton AS, George JM, Rienstra CM, (2011) Structured regions of a-synuclein fibrils include the early-onset Parkinson's disease mutation sites. J Mol Biol 411: 881-895.
72. Helmus JJ, Surewicz K, Apostol MI, Surewicz WK, Jaroniec CP, (2011) Intermolecular alignment in Y145Stop human prion protein amyloid fibrils probed by solid state NMR spectroscopy. J Am Chem Soc 133: 13934-13937.
73. Lewandowski JR, van der Wel PCA, Rigney M, Grigorieff N, Griffin RG, (2011) Structural complexity of a composite amyloid fibril. J Am Chem Soc 133: 14686-14698.
74. Parthasarathy S, Long F, Miller Y, Xiao YL, McElheny D, Thurber K, Ma BY, Nussinov R, Ishii Y, (2011) Molecular-level examination of Cu2+ binding structure for amyloid fibrils of 40-residue Alzheimer's Ab by solid state NMR spectroscopy. J Am Chem Soc 133: 3390-3400.
75. Schneider R, Schumacher MC, Mueller H, Nand D, Klaukien V, Heise H, Riedel D, Wolf G, Behrmann E, Raunser S, Seidel R, Engelhard M, Baldus M, (2011) Structural characterization of polyglutamine fibrils by solid state NMR spectroscopy. J Mol Biol 412: 121-136.
76. Bedrood S, Li YY, Isas JM, Hegde BG, Baxa U, Haworth IS, Langen R, (2012) Fibril structure of human islet amyloid polypeptide. J Biol Chem 287: 5235-5241.
77. Lemkau LR, Comellas G, Kloepper KD, Woods WS, George JM, Rienstra CM, (2012) Mutant protein A30P a-synuclein adopts wild-type fibril structure, despite slower fibrillation kinetics. J Biol Chem 287: 11526-11532.
78. Hoop CL, Mishra R, Kar K, Kodali R, Wetzel R, van der Wel PCA, (2013) Structural and motional investigations of polyglutamine-containing amyloid fibrils by magic-angle-spinning solid state NMR. Biophys J 104: 181A-181A.
79. Bousset L, Pieri L, Ruiz-Arlandis G, Gath J, Jensen PH, Habenstein B, Madiona K, Olieric V, Bockmann A, Meier BH, Melki R, (2013) Structural and functional characterization of two a-synuclein strains. Nat Commun 4:[PAGE #S].
80. Van Melckebeke H, Wasmer C, Lange A, Ab E, Loquet A, Bockmann A, Meier BH, (2010) Atomic-resolution three-dimensional structure of HET-s(218-289) amyloid fibrils by solid state NMR spectroscopy. J Am Chem Soc 132: 13765-13775.
81. Goldsbury CS, Wirtz S, Muller SA, Sunderji S, Wicki P, Aebi U, Frey P, (2000) Studies on the in vitro assembly of Ab1-40: implications for the search for Ab fibril formation inhibitors. J Struct Biol 130: 217-231.
82. Jimenez JL, Nettleton EJ, Bouchard M, Robinson CV, Dobson CM, Saibil HR, (2002) The protofilament structure of insulin amyloid fibrils. Proc Natl Acad Sci USA 99: 9196-9201.
83. Meinhardt J, Sachse C, Hortschansky P, Grigorieff N, Fandrich M, (2009) Ab(1-40) fibril polymorphism implies diverse interaction patterns in amyloid fibrils. J Mol Biol 386: 869-877.
84. Chen B, Thurber KR, Shewmaker F, Wickner RB, Tycko R, (2009) Measurement of amyloid fibril mass-per-length by tilted-beam transmission electron microscopy. Proc Natl Acad Sci U S A 106: 14339-14344.
85. Goldsbury C, Frey P, Olivieri V, Aebi U, Muller SA, (2005) Multiple assembly pathways underlie amyloid-b fibril polymorphisms. J Mol Biol 352: 282-298.
86. Kodali R, Williams AD, Chemuru S, Wetzel R, (2010) Ab(1-40) forms five distinct amyloid structures whose b-sheet contents and fibril stabilities are correlated. J Mol Biol 401: 503-517.
87. Klunk WE, Lopresti BJ, Debnath ML, Holt DP, Wang YM, Huang GF, Shao L, Lefterov I, Koldamova R, Ikonomovic M, DeKosky ST, Mathis CA, (2004) Amyloid deposits in transgenic PS1/APP mice do not bind the amyloid PET tracer, PIB, in the same manner as human brain amyloid. Neurobiol Aging 25: S232-S233.
88. Nilsson KPR, Aslund A, Berg I, Nystrom S, Konradsson P, Herland A, Inganas O, Stabo-Eeg F, Lindgren M, Westermark GT, Lannfelt L, Nilssonl LNG, Hammarstrom P, (2007) Imaging distinct conformational states of amyloid-b fibrils in Alzheimer's disease using novel luminescent probes. ACS Chem Biol 2: 553-560.
89. McDonald M, Box H, Bian W, Kendall A, Tycko R, Stubbs G, (2012) Fiber diffraction data indicate a hollow core for the Alzheimer's Ab 3-fold symmetric fibril. J Mol Biol 423: 454-461.
90. Gath J, Bousset L, Habenstein B, Melki R, Bockmann A, Meier BH, (2014) Unlike twins: An NMR comparison of two a-synuclein polymorphs featuring different toxicity. PLoS One 9:[PAGES].
91. Daebel V, Chinnathambi S, Biernat J, Schwalbe M, Habenstein B, Loquet A, Akoury E, Tepper K, Muller H, Baldus M, Griesinger C, Zweckstetter M, Mandelkow E, Vijayan V, Lange A, (2012) β-sheet core of tau paired helical filaments revealed by solid state NMR. J Am Chem Soc 134: 13982-13989.
92. Toyama BH, Kelly MJS, Gross JD, Weissman JS, (2007) The structural basis of yeast prion strain variants. Nature 449: 233-U238.
93. Luckgei N, Schutz AK, Bousset L, Habenstein B, Sourigues Y, Gardiennet C, Meier BH, Melki R, Bockmann A, (2013) The conformation of the prion domain of Sup35p in isolation and in the full-length protein. Angew Chem-Int Edit 52: 12741-12744.
94. Frederick KK, Debelouchina GT, Kayatekin C, Dorminy T, Jacavone AC, Griffin RG, Lindquist S, (2014) Distinct prion strains are defined by amyloid core structure and chaperone binding site dynamics. Chem Biol 21: 295-305.
95. Jones EM, Surewicz WK, (2005) Fibril conformation as the basis of species- and strain-dependent seeding specificity of mammalian prion amyloids. Cell 121: 63-72.
96. Cobb NJ, Apostol MI, Chen SG, Smirnovas V, Surewicz WK, (2014) Conformational stability of mammalian prion protein amyloid fibrils is dictated by a packing polymorphism within the core region. J Biol Chem 289: 2643-2650.
97. Lomakin A, Chung DS, Benedek GB, Kirschner DA, Teplow DB, (1996) On the nucleation and growth of amyloid b-protein fibrils: detection of nuclei and quantitation of rate constants. Proc Natl Acad Sci USA 93: 1125-1129.
98. Lomakin A, Teplow DB, Kirschner DA, Benedek GB, (1997) Kinetic theory of fibrillogenesis of amyloid b-protein. Proc Natl Acad Sci USA 94: 7942-7947.
99. Chen SM, Ferrone FA, Wetzel R, (2002) Huntington's disease age-of-onset linked to polyglutamine aggregation nucleation. Proc Natl Acad Sci USA 99: 11884-11889.
100. Cohen SIA, Vendruscolo M, Dobson CM, Knowles TPJ, (2011) Nucleated polymerization with secondary pathways. II. Determination of self-consistent solutions to growth processes described by non-linear master equations. J Chem Phys 135: 065106.
101. Cohen SIA, Vendruscolo M, Dobson CM, and Knowles TPJ, (2011) Nucleated polymerization with secondary pathways. III. Equilibrium behavior and oligomer populations. J Chem Phys 135: 065107.
102. Cohen SIA, Vendruscolo M, Welland ME, Dobson CM, Terentjev EM, Knowles TPJ, (2011) Nucleated polymerization with secondary pathways. I. Time evolution of the principal moments. J Chem Phys 135: 065105.
103. Cohen SIA, Linse S, Luheshi LM, Hellstrand E, White DA, Rajah L, Otzen DE, Vendruscolo M, Dobson CM, Knowles TPJ, (2013) Proliferation of amyloid-b42 aggregates occurs through a secondary nucleation mechanism. Proc Natl Acad Sci USA 110: 9758-9763.
104. Collinge J, Sidle KCL, Meads J, Ironside J, Hill AF, (1996) Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature 383: 685-690.
105. Safar J, Wille H, Itrri V, Groth D, Serban H, Torchia M, Cohen FE, Prusiner SB, (1998) Eight prion strains have PrPSc molecules with different conformations. Nat Med 4: 1157-1165.
106. Collinge J, Clarke AR, (2007) A general model of prion strains and their pathogenicity. Science 318: 930-936.
107. Wickner RB, Shewmaker F, Edskes H, Kryndushkin D, Nemecek J, McGlinchey R, Bateman D, Winchester CL, (2010) Prion amyloid structure explains templating: How proteins can be genes. FEMS Yeast Res 10: 980-991.
108. Tanaka M, Collins SR, Toyama BH, Weissman JS, (2006) The physical basis of how prion conformations determine strain phenotypes. Nature 442: 585-589.
109. Cameron B, Landreth GE, (2010) Inflammation, microglia, and Alzheimer's disease. Neurobiol Dis 37: 503-509.
110. Meyer-Luehmann M, Coomaraswamy J, Bolmont T, Kaeser S, Schaefer C, Kilger E, Neuenschwander A, Abramowski D, Frey P, Jaton AL, Vigouret JM, Paganetti P, Walsh DM, Mathews PM, Ghiso J, Staufenbiel M, Walker LC, Jucker M, (2006) Exogenous induction of cerebral b-amyloidogenesis is governed by agent and host. Science 313: 1781-1784.
111. Langer F, Eisele YS, Fritschi SK, Staufenbiel M, Walker LC, Jucker M, (2011) Soluble Ab seeds are potent inducers of cerebral b-amyloid deposition. J Neurosci 31: 14488-14495.
112. Stohr J, Watts JC, Mensinger ZL, Oehler A, Grillo SK, DeArmond SJ, Prusiner SB, Giles K, (2012) Purified and synthetic Alzheimer's amyloid b (Ab) prions. Proc Natl Acad Sci USA 109: 11025-11030.